Calls for mammograms at age 40 for low-risk patients amid rise in breast cancer in younger women
Clinical Topics
First OTC Birth Control Pill Wins FDA Approval
UPDATE: FDA gave Opill full approval on July 13, 2023. Advisers to the Food and Drug Administration (FDA) have voted…
Special Risks of Psoriasis in Your Patients
Red Flag for Alcohol Concerns and Other Care Considerations
Preeclampsia Risk Test Gets FDA Nod
The Food and Drug Administration (FDA) has cleared the first blood-based biomarkers assay for risk assessment and clinical management of…
USPSTF Issues First-Ever Advice on Anxiety Screening
New Guidelines Alert Primary Care Providers to Screen Adults, Including Pregnant and Postpartum Women